These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 17060217)
1. Reasons for participation and non-participation in a randomized controlled trial: postal questionnaire surveys of women eligible for TOMBOLA (Trial Of Management of Borderline and Other Low-Grade Abnormal smears). Sharp L; Cotton SC; Alexander L; Williams E; Gray NM; Reid JM; Clin Trials; 2006; 3(5):431-42. PubMed ID: 17060217 [TBL] [Abstract][Full Text] [Related]
2. Developing a questionnaire to measure the psychosocial impact of an abnormal cervical smear result and its subsequent management: the TOMBOLA (Trial of Management of Borderline and Other Low-grade Abnormal Smears) trial. Gray NM; Sharp L; Cotton SC; Avis M; Philips Z; Russell I; Walker LG; Whynes D; Little J; Qual Life Res; 2005 Aug; 14(6):1553-62. PubMed ID: 16110935 [TBL] [Abstract][Full Text] [Related]
3. Psychological effects of a low-grade abnormal cervical smear test result: anxiety and associated factors. Gray NM; Sharp L; Cotton SC; Masson LF; Little J; Walker LG; Avis M; Philips Z; Russell I; Whynes D; Cruickshank M; Woolley CM; Br J Cancer; 2006 May; 94(9):1253-62. PubMed ID: 16622462 [TBL] [Abstract][Full Text] [Related]
4. After-effects reported by women having follow-up cervical cytology tests in primary care: a cohort study within the TOMBOLA trial. Cotton S; Sharp L; Cochran C; Gray N; Cruickshank M; Smart L; Thornton A; Little J; Br J Gen Pract; 2011 Jun; 61(587):e333-9. PubMed ID: 21801512 [TBL] [Abstract][Full Text] [Related]
5. Women's knowledge about cervical cancer risk factors, screening, and reasons for non-participation in cervical cancer screening programme in Estonia. Kivistik A; Lang K; Baili P; Anttila A; Veerus P BMC Womens Health; 2011 Sep; 11():43. PubMed ID: 21951661 [TBL] [Abstract][Full Text] [Related]
6. Psychosocial outcomes of three triage methods for the management of borderline abnormal cervical smears: an open randomised trial. McCaffery KJ; Irwig L; Turner R; Chan SF; Macaskill P; Lewicka M; Clarke J; Weisberg E; Barratt A BMJ; 2010 Feb; 340():b4491. PubMed ID: 20179125 [TBL] [Abstract][Full Text] [Related]
7. Improving participation rates by providing choice of participation mode: two randomized controlled trials. Heijmans N; van Lieshout J; Wensing M BMC Med Res Methodol; 2015 Apr; 15():29. PubMed ID: 25886757 [TBL] [Abstract][Full Text] [Related]
8. [Study of the factors motivating refusal of women to participate to a randomized clinical trial in gynecological surgery. Retrospective observational bicentric study]. Nguyen-Xuan HT; Thiollier G; Ruault O; Fauconnier A; Lucot JP; Bader G J Gynecol Obstet Biol Reprod (Paris); 2016 Nov; 45(9):1054-1059. PubMed ID: 27114064 [TBL] [Abstract][Full Text] [Related]
9. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the TOMBOLA randomised controlled trial. Sharp L; Cotton S; Little J; Gray NM; Cruickshank M; Smart L; Thornton A; Waugh N; Walker L; PLoS One; 2013; 8(12):e80092. PubMed ID: 24386076 [TBL] [Abstract][Full Text] [Related]
10. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
11. Motivators for women to attend cervical screening: the influential role of GPs. O'Connor M; Murphy J; Martin C; O'Leary J; Sharp L; Fam Pract; 2014 Aug; 31(4):475-82. PubMed ID: 24927724 [TBL] [Abstract][Full Text] [Related]
12. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial. Lilliecreutz C; Karlsson H; Spetz Holm AC PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875 [TBL] [Abstract][Full Text] [Related]
13. Management of low-grade cervical abnormalities detected at screening: which method do women prefer? Whynes DK; Woolley C; Philips Z; Cytopathology; 2008 Dec; 19(6):355-62. PubMed ID: 18522634 [TBL] [Abstract][Full Text] [Related]
15. Women's experience of coping with a positive Pap smear: A register-based study of women with two consecutive Pap smears reported as CIN 1. Ideström M; Milsom I; Andersson-Ellström A Acta Obstet Gynecol Scand; 2003 Aug; 82(8):756-61. PubMed ID: 12848648 [TBL] [Abstract][Full Text] [Related]
16. Enclosing a pen with a postal questionnaire can significantly increase the response rate. Sharp L; Cochran C; Cotton SC; Gray NM; Gallagher ME; J Clin Epidemiol; 2006 Jul; 59(7):747-54. PubMed ID: 16765279 [TBL] [Abstract][Full Text] [Related]
17. Patient perceptions of the challenges of recruitment to a renal randomised trial registry: a pilot questionnaire-based study. Murphy E; O'Keeffe A; O Shea N; Long E; Eustace JA; Shiely F Trials; 2021 Sep; 22(1):597. PubMed ID: 34488851 [TBL] [Abstract][Full Text] [Related]
18. [Women's social conditions and their participation in Cervical Cancer Population Screening Program in Poland]. Spaczyński M; Nowak-Markwitz E; Januszek-Michalecka L; Karowicz-Bilińska A Ginekol Pol; 2009 Nov; 80(11):833-8. PubMed ID: 20088397 [TBL] [Abstract][Full Text] [Related]
19. Why don't women participate? A qualitative study on non-participation in a surgical randomised controlled trial. Gopinath D; Smith AR; Holland C; Reid FM Int Urogynecol J; 2013 Jun; 24(6):969-75. PubMed ID: 23114890 [TBL] [Abstract][Full Text] [Related]
20. Women's views regarding participation in a proposed randomized controlled trial of twin delivery. McLeod L; Barrett J; Hewson S; Hannah ME J Obstet Gynaecol Can; 2004 Jun; 26(6):575-9. PubMed ID: 15193203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]